5Cohen Y,Singer G,Lavie O,et al.The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix[J].Clin Cancer Res,2003,9(8):2981-2984.
6Kang S,Kim JW,Kang GH,et al.Comparison of DNA hypermethylation patterns in different types of uterine cancer:cervical squamous cell carcinoma,cervical adenocarcinoma and endometrial adenocarcinoma[J].Int J Cancer,2006 118(9):2168-2171.
二级参考文献12
1Yu MY, Tong JHM, Chan PKS, et al. Hypermethylation of the tumor suppressor gene RASSF1A and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers[J]. Int J Cancer, 2003, 105 (2):204-209.
2Ip SM, D PH, Wong LC, et al. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of upper genital tract[J].Gynecologic Oncology, 2002, 87(1): 104-111.
3Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a ras association domain family protein from the lung tumor suppressor locus 3p21.3[J]. Nat Genet, 2000, 25 (3):315-319.
4Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumors[J]. Oncogene, 2001, 20(12): 1509-1518.
5Schagdarsurengin U, Gimm O, Hoang-Vu C, et al. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in throid carcinoma[J].Cancer Res, 2002, 62(13): 3698-3701.
6Spugnardi M, Tommasi S, Dammann R, et al. Epigenetic inactivation of Ras association domain family protein 1(RASSF1A)in malignant cutaneous melanoma[J]. Cancer Res, 2003, 63(7): 1639-1643.
7Shivakumar L, Minna J, Sakamaki T, et al. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclinD1 accumulation[J]. Molecular and Cellular Biology, 2002, 22(12):4309-4318.
8Byun DS, Lee MG, Chae KS, et al. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma[J]. Cancer Res, 2001,61(19): 7034-7038.
9Maruyama R, Toyooka S, Kiyomi O, et al. Aberrant promoter met-hylation profile of prostate cancers and its relationship to clinicopat-hological features[J].Clinical Cancer Research, 2002, 8 (2):514-519.
10Hogg RP, Honorio S, Martinez A, et al. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumor suppressor gene from region 3p21.3 in head and neck squamous cell carcinomas[J]. Eur J Cancer, 2002, 38(12): 1585-1592.
3Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum[J].Cancer Res, 2000,60(21 ) :5954 -5958.
4Pollack IF, Hamilton RL, Sobol RW, et al. O^6-methylguanine- DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas:results from the CCG-945 Cohort [J]. J Clin Oncol,2006 ,24(21 ) :3431 -3437.
5Dong SM, Kim HS, Rha SH, et al. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix[J]. Clin Cancer Res,2001,7(7) :1982 - 1986.
6Yang HJ, Liu VW, Wang Y, et al. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients[ J]. Gynecol Oncol,2004,93 (2) :435 - 440.
7Dong SM, Kim HS, Rha SH, et al. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix[ J]. Clin Cancer Res,2001,7(7) : 1982 - 1986.
8Jing F,Yuping W,Yong C,et al.CpG island methylator phenotype of muhigene in serum of sporadic breast carcinoma[J].Tumour Biol,2010,31 (4):321 -331.
9S Narayon,S Victor,S Makoto,et al.Application of a methylation gene panel by quantitative PCR for lung cancers[J].Cancer Letters,2007,247:56 - 71.
10K Hideki,H Akio,A Keisuke,et al.Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion[J].Int.J.Cancer,2007,120,2191 -2195.
